Home
Conditions
Inflammatory Bowel Disease (IBD)

Clinical trial condition

Inflammatory Bowel Disease (IBD)

Explore clinical trials studying Inflammatory Bowel Disease (IBD). Study availability and eligibility vary by location and protocol.

98 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Inflammatory Bowel Disease (IBD) trial results

Active, not recruiting

A Clinical Study on The Use of DL-endopeptidase-producing Probiotics as an Adjunctive Therapy for Inflammatory Bowel Disease.

NCT07318753

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +7 more
Locations: Shenzhen Hospital of Southern Medical University Shenzhen, Guangdong, China

View Trial Details

Active, not recruiting

Oral Microbiota Dysbiosis in IBD

NCT06980818

Conditions: Digestive System Diseases, Dysbiosis, Gastroenteritis, +6 more
Locations: ULS Viseu Dão-Lafões Viseu, Viseu District, Portugal

View Trial Details

Completed

Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease

NCT07697547

Conditions: Crohn Disease, Crohn's Disease, Digestive System Diseases, +5 more
Locations: The Tenth People's Hospital of Shanghai Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

NCT05384080

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +9 more
Locations: Uniwersytecki Szpital Kliniczny Wroclaw, Dolnoslskie, Poland

Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Miedzychodzie Międzychód, Greater Poland Voivodeship, Poland

Szpital Kliniczny Im. Heliodora Swiecickiego Uniwersytetu Medycznego Im. Karola Marcinkowskiego W Poznaniu Poznan, Greater Poland Voivodeship, Poland

Szpital Uniwersytecki Nr 2 Im. Dr Jana Biziela W Bydgoszczy Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

View Trial Details

Completed

VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation

NCT07273760

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +9 more
Locations: Dr. Mohammad-Javad Kaviani Clinic Shiraz, Fars, Iran

Gilan Gastroenterology and Hepatology Subspecialty Clinic Rasht, Gilan Province, Iran

Dr. Ali Beheshti-Namdar Clinic Mashhad, Razavi Khorasan Province, Iran

Dr. Hassan Vossoughinia Clinic Mashhad, Razavi Khorasan Province, Iran

View Trial Details

Completed

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

NCT01022749

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +10 more
Locations: CIC Vaccinologie Hopital Cochin Paris, France

View Trial Details

Completed

Nutrition, Meal Regularity and Quality of Life in Inflammatory Bowel Disease

NCT07179965

Conditions: Behavior, Behavior, Animal, Diet Habits, +12 more
Locations: Istanbul University Cerrahpaşa Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Kinetics and Metabolism of Nicotinamide Provided as a Dietary Supplementation

NCT07156929

Conditions: Bronchial Diseases, Bronchitis, COPD Acute Exacerbation, +24 more
Locations: University Hospital Schleswig-Holstein, Campus Kiel Kiel, Schleswig-Holstein, Germany

View Trial Details

Completed

Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes

NCT04345393

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +3 more
Locations: University of California, Davis Davis, California, United States

RxHealth Secaucus, New Jersey, United States

Icahn School of Medicine at Mount Sinai New York, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Completed

Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency

NCT05078879

Conditions: Crohn Disease, Crohn's Disease, Digestive System Diseases, +6 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD) trial results

Related conditions